Module 3: MPS and Alpha–mannosidosis: Challenges in Disease Management – Orthopaedics

Organised: Wed, Feb 5, 2020 
Time: 1:00 pm - 2:00 pm CET (Central European Time)
Presenter: ANDREA BORGO

You can still attend the session. Click Here to Register and watch the recorded video. It's free

Andrea Borgo is Orthopaedic Surgeon and Assistant Professor at the Orthopaedic Clinic, University General Hospital of Padova, Italy

  • Duration:30 min followed by Q&A
  • Language: English
  • Audience: Pediatricians, General Practitioners, Orthopedists 

The online session is free to attend, and a certificate of attendance will be provided by the Excellence in Pediatrics Institute for those who will attend. As soon as you register for the selected module you will also be registered for all the modules of the course.

Module Learning Objectives

(1) Know what are the musculoskeletal manifestations of mucopolysaccharidoses and Alpha-mannosidosis (2) Recognize some precocious musculoskeletal signs suggestive for a metabolic disease in order to send the patients to the right diagnostic pathway (3) Understand the orthopaedic surgical options (and their timing) in a child affected by mucopolysaccharidoses.


Click Here to Register and watch the recorded video. It's free

Important Note: The information provided on this session is intended and designed for use by healthcare professionals with an interest in metabolic diseases, MPS and alpha-mannosidosis. All session viewers are required to register for the selected webinar before accessing the content. Content and views shared are solely those of the speaker.

The free-to-attend online course has been designed to help specialists and general paediatricians to reduce delay in the referral and diagnosis of patients with suspected MPS and alpha-mannosidosis, as well as improving the quality of patient’s lives who have already been diagnosed. On-time diagnosis is crucial for access to treatment and clinical trials, disease management and to access the proper care services at the earliest of the disease possible.

The course is an MPS Europe project in partnership with MetabERN and the Excellence in Pediatrics with the support of Biomarin, Chiesi, Orchard Therapeutics, Regenxbio, Sanofi Genzyme, Takeda, and Ultragenyx. All modules of the course are independently organised by EIP in terms of content, topics and speakers appointed. 

 

get updates

connect